Non-specific protection from respiratory tract infections in cattle generated by intranasal administration of an innate immune stimulant.

Abstract

Alternatives to antibiotics for prevention of respiratory tract infections in cattle are urgently needed given the increasing public and regulatory pressure to reduce overall antibiotic usage. Activation of local innate immune defenses in the upper respiratory tract is one strategy to induce non-specific protection against infection with the diverse array of viral and bacterial pathogens associated with bovine respiratory disease complex (BRDC), while avoiding the use of antibiotics. Our prior studies in rodent models demonstrated that intranasal administration of liposome-TLR complexes (LTC) as a non-specific immune stimulant generated high levels of protection against lethal bacterial and viral pathogens. Therefore, we conducted studies to assess LTC induction of local immune responses and protective immunity to BRDC in cattle. In vitro, LTC were shown to activate peripheral blood mononuclear cells in cattle, which was associated with secretion of INFγ and IL-6. Macrophage activation with LTC triggered intracellular killing of Mannheimia hemolytica and several other bacterial pathogens. In studies in cattle, intranasal administration of LTC demonstrated dose-dependent activation of local innate immune responses in the nasopharynx, including recruitment of monocytes and prolonged upregulation (at least 2 weeks) of innate immune cytokine gene expression by nasopharyngeal mucosal cells. In a BRDC challenge study, intranasal administration of LTC prior to pathogen exposure resulted in significant reduction in both clinical signs of infection and disease-associated euthanasia rates. These findings indicate that intranasal administration of a non-specific innate immune stimulant can be an effective method of rapidly generating generalized protection from mixed viral and bacterial respiratory tract infections in cattle.

• Authors: William Wheat, Lyndah Chow, Vanessa Rozo, Julia Herman, Kelly Still Brooks, Aimee Colbath, Randy Hunter, Steven Dow
• Journal: PloS one (PLoS One) Vol. 15 Issue 6 Pg. e0235422 ( 2020) ISSN: 1932-6203 [Electronic] United States
• PMID: 32584899 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Histocompatibility Antigens Class II
• Interleukin-6
• Liposomes
• Respiratory System Agents
• Toll-Like Receptor 3
• Toll-Like Receptor 9
• Nitric Oxide
• Interferon-gamma

Topics

• Administration, Intranasal
• Animals
• Bovine Respiratory Disease Complex (drug therapy, mortality, pathology)
• Cattle
• Histocompatibility Antigens Class II (metabolism)
• Immunity, Innate (drug effects)
• Interferon-gamma (genetics, metabolism)
• Interleukin-6 (genetics, metabolism)
• Leukocytes, Mononuclear (cytology, metabolism)
• Liposomes (chemistry)
• Macrophages (cytology, drug effects, immunology, metabolism)
• Mannheimia haemolytica (isolation & purification, pathogenicity)
• Nasopharynx (metabolism, microbiology)
• Nitric Oxide (metabolism)
• Phagocytosis
• Respiratory System Agents (pharmacology, therapeutic use)
• Survival Rate
• Toll-Like Receptor 3 (agonists)
• Toll-Like Receptor 9 (agonists)
• Up-Regulation (drug effects)